Insights

Gathering insights about BioPacific Investors…

Similar companies to BioPacific Investors

BioPacific Investors Tech Stack

Media & News

BioPacific Investors's Email Address Formats

BioPacific Investors uses at least 1 format(s):

BioPacific Investors Email Formats	Example	Percentage
First.Last@biopacificinvestors.com	John.Doe@biopacificinvestors.com	25%
FLast@biopacificinvestors.com	JDoe@biopacificinvestors.com	25%
First.Last@biopacificinvestors.com	John.Doe@biopacificinvestors.com	25%
FLast@biopacificinvestors.com	JDoe@biopacificinvestors.com	25%

Frequently Asked Questions

What is BioPacific Investors's official website and social media links?

BioPacific Investors's official website is biopacificinvestors.com and has social profiles on LinkedIn.

What is BioPacific Investors's SIC code NAICS code?

BioPacific Investors's SIC code is 6371 - Pension, Health, and Welfare Funds NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does BioPacific Investors have currently?

As of December 2025, BioPacific Investors has approximately 3 employees across 1 continents, including North America. Key team members include Member: T. K.. Explore BioPacific Investors's employee directory with LeadIQ.

What industry does BioPacific Investors belong to?

BioPacific Investors operates in the Venture Capital and Private Equity Principals industry.

What is BioPacific Investors's email format?

BioPacific Investors's email format typically follows the pattern of First.Last@biopacificinvestors.com. Find more BioPacific Investors email formats with LeadIQ.

When was BioPacific Investors founded?

BioPacific Investors was founded in 2013.

BioPacific Investors

Q: How many employees does BioPacific Investors have currently?

BioPacific Investors has approximately 3 employees.

Venture Capital and Private Equity PrincipalsCalifornia, United States2-10 Employees

A new angel investment group created to leverage cross-border opportunities in early stage life science and healthcare. Will focus on US-based life science and healthcare companies with China/Asia as a key component of their business strategy. Seed or Series A funding of $250K to $1M. Access to government and VC follow-on funding in China.  No fee to apply or present, but subject to screening process approval.